03/01
Headlines

NPS Pharmaceuticals

Stocks in Focus : MGM Resorts (NYSE:MGM), NPS Pharmaceuticals (NASDAQ:NPSP), LeMaitre Vascular (NASDAQ:LMAT), Range Resources (NYSE:RRC), BlackRock Maryland Municipal (NYSEMKT:BZM)

Jason Knox03 mins

The Women’s Leadership Conference announces its 2014 program featuring two days of keynote speakers, breakout sessions, luncheons and networking opportunities. The conference, themed “Women Inspiring Women,” will be held Aug. 6 & 7 at the MGM Resorts International (NYSE:MGM) Grand Conference Center in Las Vegas. MGM Resorts International (NYSE:MGM)’s stock on 30 July traded at…

Read More

Morning Buzz – Yahoo! Inc. (NASDAQ:YHOO) , Reynolds American , Realogy (NYSE:RLGY) , NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) , ESB Financial Corporation (NASDAQ:ESBF)

Mark Doerr03 mins

Yahoo! Inc. (NASDAQ:YHOO) announced Monday it reached a definitive agreement to acquire six-year-old mobile analytics startup Flurry. Yahoo! Inc. (NASDAQ:YHOO) stock performance was -0.15% in last session and finished the day at $33.28. Traded volume was 18.43million shares in the last session and the average volume of the stock remained 19.69million shares. The beta of…

Read More
FB Nasdaq FB Facebook

Healthcare Active Stocks: AstraZeneca plc (ADR) (NYSE:AZN), NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Gilead Sciences, Inc. (NASDAQ:GILD)

Mark DeFrance03 mins

AstraZeneca Plc (ADR) (NYSE:AZN), in the headlines for spurning buyout offers from Pfizer Inc, aims to regain prominence in oncology with compelling trial results and a splashy exhibit booth at the world’s largest meeting of cancer doctors. AstraZeneca plc (ADR) (NYSE:AZN) stock performance was -0.83% in last session and finished the day at $72.76. Traded…

Read More
FB Nasdaq FB Facebook

Healthcare Gainers: BioScrip Inc (NASDAQ:BIOS), NPS Pharmaceuticals (NASDAQ:NPSP), RadNet Inc. (NASDAQ:RDNT), Avanir Pharmaceuticals Inc (NASDAQ:AVNR)

Richard Atkins02 mins

BioScrip Inc (NASDAQ:BIOS), on May 8, 2014 announced 2014 first quarter financial results. First quarter revenue from continuing operations was $239.6 million and the net loss from continuing operations was $25.4 million, or $0.37 per basic and diluted share. Non-GAAP adjusted loss from continuing operations per basic and diluted share was $0.13.BioScrip Inc (NASDAQ:BIOS) stock…

Read More